Skip to main content
OpenTrials
Completed

NCT Number: NCT05092399

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

The investigators are therefore interested to explore the effects of VLCD and different bariatric surgery procedures to changes in the physical deposition of fat in organs which regulate glucose metabolism (i.e. in the liver, pancreas, muscle) in the earlier (6 weeks) and intermediate (4 months) period after bariatric surgery, where rate of weight loss at this stage are similar between the two procedures. Increased understanding of the changes in these important metabolic organs, will increase the investigators' understanding of mechanism of diabetes remission following bariatric surgery, their effects on weight loss or changes in gut hormones levels. Magnetic Resonance imaging (MRI) and Magnetic Resonance spectroscopy (MRS) are non-invasive, non-ionising techniques. MRI can be used to investigate the body's physiology and MRS can be used to investigate the body's metabolic processes, so by combining these two methods the investigators are able to investigate the process of fat reduction and diabetes remission post gastric surgery without performing any secondary invasive procedures The purpose of this project is to investigate the effects of a Very Low Calorie Diet (VLCD) followed by two different bariatric surgical procedures, Roux-en-Y Gastric Bypass (RYGB) and Sleeve gastrectomy (SG) on skeletal muscle, liver and pancreatic fat deposition, ATP flux as well as cardiac function.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Royal Derby Hospital

Derby, Derbyshire, DE22 3NE, United Kingdom

About this study

There are NO research interventions, this study is observing a patient's response to clinical interventions. The below describes the investigators methods of observation.

Screening:

Participants who are listed for surgery by the Bariatric surgical Tier 4 MDT team will be approached by one of the main care team who may also be a member of the research team during the ERAS session (Enhanced Recovery After Surgery) approximately 6 months before surgery. If the participants wish to partake in the study the will be then screened for ability and willingness to undergo MRI in order to prevent any wasting of the patients time and prevent unnecessary data storage. If eligible and consent is provided, their details will be kept by the research team to be contacted for further appointment to attend the investigators University of Nottingham (UoN) research unit based at the Royal Derby Hospital.

There are 2 main arms to the study, consists of 2 arms, patients undergoing RYGB (group 1) and Patients undergoing SG (group 2) Within these groups there are category A and B participants.

Category A - Primary Study - Participants who will be used to investigate the primary and secondary outcomes.

Category B - Exploratory sub-study - Participants will be used to investigate the Primary outcome but also as a pilot set of data for cardiac measures.

At all category A sessions Participants will be asked to attend a session at the Sir Peter Mansfield Imaging Centre (SPMIC) on the UoN main campus.

The participants will receive an MRI and MRS scan, a Blood Test and a liquid mixed meal test at every session. The mixed meal test is not apart of routine care, in this study it shall be used to examine the change in participants response to a meal after each clinical intervention (VLCD and Surgery). Blood samples will be taken by a trained member of staff and transferred to the Royal Derby Hospital for testing, this is to obtain Glucose, Ghrelin, C-peptide, glucagon and total and intact glucagon-like peptide-1 (GLP-1).

Participants in category B will be asked to attend sessions at the SPMIC. And will only receive MRI and MRS scans.

Session 1:

A member of the research team will reach out to the patient 2 weeks prior to the commencement of their VLCD in order to confirm the participants are still interested in participating, book in the first study session and answer any questions the participants may have.

Session 2:

Between 3 and 1 day prior to the commencement of the VLCD.

Category A:

The MRI protocol for this session physiology scans of the Chest, Abdomen and Skeletal Muscle (thigh) and MRS is proton spectroscopy performed on the Liver. Participants will be in the scanner for no longer than 1 hour.

Category B:

Basic Cardiac measures using MRI will be used in planning for Proton and Phosphorus MR Spectroscopy (MRS). Participants will be offered a break after being in the scanner for 1hour with a maximum time in the scanner of 2hours.

Session 3:

Between 3 and 1 day prior to the Participants Bariatric Surgery.

Category A:

The MRI protocol for this session is physiology scans for the Chest, Abdomen and Skeletal Muscle (thigh) and MRS is proton spectroscopy and a 31P (phosphorous) spectroscopy performed on the Liver. Basic. Participants will be offered a break after being in the scanner for 1hour with a maximum time in the scanner of 2hours.

Category B:

Basic Cardiac measures using MRI will be used in planning for Proton and Phosphorus MR Spectroscopy (MRS). Participants will be offered a break after being in the scanner for 1hour with a maximum time in the scanner of 2hours

Surgery:

Roux-en-Y Gastric Bypass (RYGB): Follows standard clinical practice. Sleeve Gastrectomy (SG): Follows standard clinical practice.

Session 4:

6 weeks post Bariatric Surgery.

Category A:

The MRI protocol for this session is physiology scans of the Chest, Abdomen and Skeletal Muscle (thigh) and MRS is proton spectroscopy and a 31P (phosphorous) spectroscopy performed on the Liver. Participants will be offered a break after being in the scanner for 1hour with a maximum time in the scanner of 2hours.

Category B:

Basic Cardiac measures using MRI will be used in planning for Proton MR Spectroscopy (MRS). Participants will be in the scanner for no longer than 1 hour.

Session 5:

16 weeks post Bariatric Surgery.

Category A:

The MRI protocol for this session is physiology scans of the Chest, Abdomen and Skeletal Muscle (thigh) and MRS is proton spectroscopy on the Liver. Participants will be in the scanner for no longer than 1 hour.

Category B:

Basic Cardiac measures using MRI will be used in planning for Proton MR Spectroscopy (MRS). Participants will be in the scanner for no longer than 1 hour.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Listed for RYCG or SG at the royal derby hospital
  • BMI>/=18
  • Type 2 diabetes
  • Ability to give informed consent

Exclusion criteria

  • If they are not suitable for either RYGB or SG as determined by the MDT meeting
  • BMI>60
  • Liver cirrhosis.
  • Participants will be excluded if they are deemed unfit for an MRI via the standard safety screening form.
  • Participants will be excluded if their waist circumference is too large for them to safely fit inside the bore of the MRI with surface coils added.
  • Participation in other research projects

Treatment and study plan

bariatric surgery

Procedure

No study interventions

Primary outcomes

  1. Effects of VLCD

    Time frame: baseline to +2weeks

    Changes to liver fat volume due to VLCD as measured with MRI

Secondary outcomes

  1. Effects of VLCD on Liver and Pancreas

    Time frame: baseline to +2weeks

    Changes to live and pancreatic fat as measured using MRI and MRS as measured as percentage fat in tissue.

  2. Effects of VLCD and bariatric surgery

    Time frame: +2weeks to +6weeks(post surgery)

    Changes to Skeletal muscle liver and pancreatic fat as measured using MRI and MRS as measured as percentage fat in tissue.

  3. Effects of VLCD and bariatric surgery

    Time frame: +6weeks(post surgery) to +4months (post surgery)

    Changes to Skeletal muscle, liver and pancreatic fat as measured using MRI and MRS as measured as percentage fat in tissue

  4. Effects of VLCD and bariatric surgery

    Time frame: +2weeks to +6weeks (post surgery)

    Changes to Liver ATP flux as measured using MRS

  5. Effects of VLCD and bariatric surgery

    Time frame: +6weeks (post surgery) to +4months (post surgery)

    Changes to Liver ATP flux as measured using MRS

  6. Difference between surgery types (RYGB Vs SG)

    Time frame: +6weeks (post surgery)

    Changes to Liver ATP flux as measured using MRS

  7. Effects of different surgery types (RYGB Vs SG) on Liver ATP flux

    Time frame: +4months (post surgery)

    Changes to Liver ATP flux as measured using MRS

  8. Effects of different surgery types (RYGB Vs SG) on Organ fat content

    Time frame: +4months (post surgery)

    Changes to skeletal muscle, liver and pancreatic fat as measured using MRI and MRS as measured as percentage fat content of tissue

  9. Difference between surgery types (RYGB Vs SG)

    Time frame: +6 weeks (post surgery)

    Changes to Skeletal muscle, liver and pancreatic fat as measured using MRI and MRS as measured as percentage fat content of tissue

  10. Effects of VLCD and bariatric surgery

    Time frame: 0 to +2weeks

    Bile Acid Quantification

  11. Effects of VLCD and bariatric surgery

    Time frame: +6weeks post surgery

    Bile Acid Quantification

  12. Effects of VLCD and bariatric surgery

    Time frame: 4months post surgery

    Bile Acid Quantification

Sponsors and collaborators

Lead sponsor

University of Nottingham

Other

Collaborators

  • International Stem Cell Forum
  • Medical Research Council
  • University Hospitals of Derby and Burton NHS Foundation Trust
  • University of Leicester

Registry information

Official study title

Differential Effects of Very Low-Calorie Diet (VLCD), Roux-En-Y-Gastric Bypass and Sleeve Gastrectomy on Pancreatic, Liver, Muscle and Heart Fat Deposition and Metabolism in People With Type 2 Diabetes: An MRI Study

Acronym: BARIATRICMRI

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Oct 25, 2021
Registry last updated
Apr 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.